ATOSSA GENETICS INC | Business Contracts

Form of Common Stock Purchase Warrant (Filed With SEC on March 23, 2021)

Form of Lock-up and Voting Agreement dated March 22, 2021 (Filed With SEC on March 23, 2021)

Form of 2020 ISO Option Award Agreement (Filed With SEC on May 13, 2020)

2010 Stock Option and Incentive Plan, as amended January 13, 2019 (Filed With SEC on January 15, 2019)

Placement Agency Agreement between Atossa Therapeutics, Inc. and Maxim Group LLC, dated March 22, 2021 (Filed With SEC on March 23, 2021)

Securities Purchase Agreement dated March 22, 2021 (Filed With SEC on March 23, 2021)

Form of Common Stock Warrant (Filed With SEC on January 8, 2021)

Placement Agency Agreement between Atossa Therapeutics, Inc. and Maxim Group LLC, dated January 6, 2021 (Filed With SEC on January 8, 2021)

Securities Purchase Agreement dated January 6, 2021 (Filed With SEC on January 8, 2021)

Form of Common Stock Private Placement Warrant (Filed With SEC on December 21, 2020)

Placement Agency Agreement between Atossa Therapeutics, Inc. and Maxim Group LLC, dated December 17, 2020 (Filed With SEC on December 21, 2020)

Securities Purchase Agreement dated December 17, 2020 (Filed With SEC on December 21, 2020)

FORM OF COMMON STOCK PURCHASE WARRANT ATOSSA THERAPEUTICS, INC. (Filed With SEC on December 14, 2020)

14,575,000 SHARES of Common Stock, 5,425 SHARES OF SERIES C CONVERTIBLE PREFERRED STOCK, AND 15,000,000 WARRANTS (EXERCISABLE for 15,000,000 shares OF COMMON STOCK) OF Atossa... (Filed With SEC on December 14, 2020)

Form of Warrant Agency Agreement (Filed With SEC on December 8, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on December 8, 2020)

Form of 2020 Warrant Agency Agreement (Filed With SEC on December 1, 2020)

Form of 2020 Warrant (Filed With SEC on December 1, 2020)

Form of Underwriting Agreement (Filed With SEC on December 1, 2020)

Equity Distribution Agreement, dated as of September 25, 2020, by and between Atossa Therapeutics, Inc. and Maxim Group LLC (Filed With SEC on September 25, 2020)

Form of 2020 Option Award Agreement (Filed With SEC on April 13, 2020)

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 26, 2020)

Equity Distribution Agreement, dated as of February 7, 2020, by and between Atossa Therapeutics, Inc. and Oppenheimer & Co. Inc (Filed With SEC on February 10, 2020)

Form of 2019 Option Award Agreement (Filed With SEC on January 15, 2019)

ATOSSA GENETICS INC (24)